Latest court orders, judgments, and legal developments from Indian courts — AI-curated and summarized.
FeaturedThe Calcutta High Court reaffirms the rights of authors in a landmark judgment enhancing their economic interests under copyright law.
FeaturedThe Delhi High Court delivers a significant decision in the ongoing litigation regarding standard essential patents, favoring Philips in a landmark verdict.
FeaturedThe Calcutta High Court reaffirmed the copyright amendments from 2012, emphasizing the rights of authors in light of recent cases involving sound recordings. The ruling highlights the economic benefits intended for authors in the copyright regime.
FeaturedAn examination of the legal restrictions on the ownership of Oscar statuettes reveals complex intersections of contract and IP law, particularly regarding the Academy's $1 rule.
FeaturedThe Delhi High Court's pro-tem order in Malikie v. Xiaomi introduces confusion into standards for assessing Standard Essential Patents (SEPs), indicating a misstep in legal reasoning that may impact future adjudications.
Delhi High Court ordered Cadila to allow Hetero’s expert access to sealed regulatory submissions in a biosimilar dispute. The unprecedented discovery ruling may set precedent for IP litigation involving complex technical data.
The Delhi High Court permitted a rival's expert to inspect confidential regulatory submissions in the Cadila-Hetero biosimilar litigation, rejecting claims of absolute confidentiality. The order precedes a Supreme Court hearing on the matter.
The DPIIT’s Draft Trade Marks Manual 2026 introduces updates but fails to address key issues like AI-generated trademarks and algorithmic examination. Stakeholders urge clarification before finalisation.
Delhi High Court allows sale of 'Yes Man: Untold Story of Rana Kapoor' after removing four defamatory passages, rejecting trial court’s complete ban as disproportionate.
The Delhi High Court permitted a plaintiff to inspect confidential regulatory submissions in a biosimilar dispute, a move with significant implications for patent litigation and data exclusivity norms.
Delhi HC permits rival’s expert to inspect Cadila’s regulatory filings in sealed cover, overriding confidentiality claims. SC to hear SLPs on 3 Nov 2026.
The Delhi High Court permitted a competing pharma company's expert to examine confidential regulatory submissions in a sealed cover, overriding claims of confidentiality. The order precedes a Supreme Court hearing on the larger biosimilar litigation between Cadila and Hetero.